BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5651455)

  • 21. [Carbohydrate metabolic disorders in gout: incidence and clinical features].
    Eliseev MS; Barskova VG
    Ter Arkh; 2010; 82(5):50-4. PubMed ID: 20597271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperuricaemia, gout, and diabetic abnormality in Polynesian people.
    Prior IA; Rose BS; Harvey HP; Davidson F
    Lancet; 1966 Feb; 1(7433):333-8. PubMed ID: 4159475
    [No Abstract]   [Full Text] [Related]  

  • 23. Gout, hyperlipidemia, and diabetes interrelationships.
    Berkowitz D
    JAMA; 1966 Jul; 197(2):77-80. PubMed ID: 5952503
    [No Abstract]   [Full Text] [Related]  

  • 24. Estimation of serum uric acid in cases of hyperuricaemia and gout.
    Pokharel K; Yadav BK; Jha B; Parajuli K; Pokharel RK
    JNMA J Nepal Med Assoc; 2011; 51(181):15-20. PubMed ID: 22335090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The kidney and hyperuricaemia (author's transl)].
    Tcherdakoff P
    Munch Med Wochenschr; 1973 Sep; 115(38):1607-11. PubMed ID: 4800872
    [No Abstract]   [Full Text] [Related]  

  • 26. [Health maintenance despite health risks. III. 3 civilization diseases: hypertension, diabetes, and gout].
    Heyden S; Wolff G
    ZFA (Stuttgart); 1976 Jun; 52(16):855-65. PubMed ID: 936757
    [No Abstract]   [Full Text] [Related]  

  • 27. [The prevalence of lipid metabolism disorders in rheumatological diseases].
    Frank O; Tidl G
    Wien Med Wochenschr; 1974 Sep; 124(37):527-30. PubMed ID: 4547104
    [No Abstract]   [Full Text] [Related]  

  • 28. [Alterations of lipid metabolism in primary gout and hyperuircemia].
    Mertz DP; Zaar I; Klöpfer-Zaar M; Henninges D; Thieme G; Scheier CA
    Dtsch Med Wochenschr; 1971 Mar; 96(12):488-93. PubMed ID: 5548321
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetes mellitus, serum urate and gout. A study in 314 patients (author's transl).
    Herzberg L
    Acta Diabetol Lat; 1973; 10(6):1202-15. PubMed ID: 4793672
    [No Abstract]   [Full Text] [Related]  

  • 30. Action of 5-thio-D-glucose on D-glucose metabolism: possible mechanism for diabetogenic effect.
    Kelley MJ; Chen TS
    J Pharmacol Exp Ther; 1985 Mar; 232(3):760-3. PubMed ID: 3919175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C14 glucose kinetic studies in normal, diabetic, and acromegalic subjects following glucose infusion.
    Manougian E; Pollycove M; Linfoot JA; Lawrence JH
    Strahlentherapie Sonderb; 1967; 65():260-70. PubMed ID: 6028428
    [No Abstract]   [Full Text] [Related]  

  • 32. Fructose-induced hyperuricaemia.
    Perheentupa J; Raivio K
    Lancet; 1967 Sep; 2(7515):528-31. PubMed ID: 4166890
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of 14C-urinary excretion and its comparison with 14CO2 in breath after 14C-urea administration in Helicobacter pylori infection.
    Pathak CM; Bhasin DK; Panigrahi D; Goel RC
    Am J Gastroenterol; 1994 May; 89(5):734-8. PubMed ID: 8172148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of 14CO2 and 3HOH from glucose-1-14C,-1-3H during oral cortisone glucose tolerance tests in obese patients.
    Shreeve WW; Tashjian AJ; Oji N; Slavinski RH; Hoshi M
    Metabolism; 1971 Mar; 20(3):280-92. PubMed ID: 5546925
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
    Mertz DP; Sulzberger I; Klöpfer M
    Munch Med Wochenschr; 1970 Feb; 112(6):241-7. PubMed ID: 5537894
    [No Abstract]   [Full Text] [Related]  

  • 36. Causes of hyperuricaemia.
    Scott JT
    Proc R Soc Med; 1969 Aug; 62(8):851-3. PubMed ID: 5810319
    [No Abstract]   [Full Text] [Related]  

  • 37. Sulphobromophthalein retention in gout and asymptomatic hyperuricaemia.
    Grahame R; Haslam RM; Scott JT
    Ann Rheum Dis; 1968 Jan; 27(1):19-26. PubMed ID: 5640839
    [No Abstract]   [Full Text] [Related]  

  • 38. [The cardiovascular risk profile in persons with normal glucose tolerance with reference to the familial occurrence of diabetes mellitus].
    Schneider H; Ziegelasch HJ
    Z Gesamte Inn Med; 1981 May; 36(9):298-300. PubMed ID: 7306279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What can asymptomatic hyperuricaemia and systemic inflammation in the absence of gout tell us?
    Inaba S; Sautin Y; Garcia GE; Johnson RJ
    Rheumatology (Oxford); 2013 Jun; 52(6):963-5. PubMed ID: 23413026
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary studies with azapropazone in gout and hyperuricaemia.
    Thomas AL; Majoos FL; Nuki G
    Eur J Rheumatol Inflamm; 1983; 6(2):149-54. PubMed ID: 6673978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.